Search

everythinglearnresearchcommunity

for

Search:↓

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Finasteride works better for baldness in people with shorter gene repeats.

Longer CAG repeats in gene linked to more severe hair loss in females.

AR gene not major factor in female hair loss; different from male hair loss.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Mutations in certain receptors can cause diseases and offer new treatment options.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Moxibustion may help improve ovarian function by changing androgen levels.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Androgens may influence bladder cancer progression by affecting cellular behavior.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Two gene areas linked to male pattern baldness found, more research needed.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Human keratinocytes do not naturally respond to androgens.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.